Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
T Koyama, K Miyakawa, R Tokumasu… - Future …, 2022 - Future Medicine
Background: Emergence of vaccine-escaping SARS-CoV-2 variants is a serious problem for
global public health. The currently rampant Omicron has been shown to possess remarkable …
global public health. The currently rampant Omicron has been shown to possess remarkable …
[HTML][HTML] Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study
A Goto, K Miyakawa, I Nakayama, S Yagome… - Frontiers in …, 2023 - frontiersin.org
Objective Despite extensive vaccination campaigns to combat the coronavirus disease
(COVID-19) pandemic, variants of concern, particularly the Omicron variant (B. 1.1. 529 or …
(COVID-19) pandemic, variants of concern, particularly the Omicron variant (B. 1.1. 529 or …
[PDF][PDF] Enhancement of humoral and cellular immunity against SARS-CoV-2 by a third dose of BNT162b2 vaccine in Japanese healthcare workers
K Miyakawa, H Kato, N Ohtake… - J. infect …, 2022 - scholar.archive.org
Abstract 1 The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) 2 has raised concerns regarding vaccine effectiveness. We investigated humoral …
CoV-2) 2 has raised concerns regarding vaccine effectiveness. We investigated humoral …
Enhancement of Humoral and Cellular Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 by a Third Dose of BNT162b2 Vaccine in Japanese …
K Miyakawa, H Kato, N Ohtake… - The Journal of …, 2023 - academic.oup.com
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
raised concerns regarding vaccine effectiveness. We investigated humoral and cellular …
raised concerns regarding vaccine effectiveness. We investigated humoral and cellular …